Serological heterogeneity against various Mycobacterium leprae antigens and its use in serodiagnosis of leprosy patients

References

1. Araoz R., Honore N., Banu S., Demangel C., Cissoko Y., Arama C., Uddin M. K. M., Abdul S. K. H., Monot M. other authors 2006; Towards an immunodiagnostic test for leprosy. Microbes Infect 8:2270–2276 [CrossRef]
   [Google Scholar]
2. Cole S. T., Eiglmeier K., Parkhill J., James K. D., Thomson N. R., Wheeler P. R., Honoré N., Garnier T., Churcher C. other authors 2001; Massive gene decay in the leprosy bacillus. Nature 409:1007–1011 [CrossRef]
   [Google Scholar]
3. Geluk A., Klein M. R., Franken K. L., van Meijgaarden K. E., Wieles B., Pereira K. C., Bührer-Sékula S., Klatser P. R., Brennan P. J. other authors 2005; Postgenomic approach to identify novel antigens of Mycobacterium leprae for improved immunodiagnosis of M. leprae infection. Infect Immun 73:5636–5644 [CrossRef]
   [Google Scholar]
4. Groathouse N. A., Amin A., Marques M. A., Spencer J. S., Gelber R., Knudson D. L., Belisle J. T., Brennan P. J., Slayden R. A. 2006; Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles. Infect Immun 74:6458–6466 [CrossRef]
   [Google Scholar]
5. Oskam L., Slim E., Buhrer-Sekula S. 2003; Serology in leprosy research and control: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev 74:196–205
   [Google Scholar]
6. Parkash O., Kumar A., Astha N., Franken K. L. M. C., Ottenhoff T. H. M. 2006a; Evaluation of recombinant serine-rich 45kDa antigen (ML0411) for detection of antibodies in leprosy patients. Scand J Immunol 64:450–455 [CrossRef]
   [Google Scholar]
7. Parkash O., Kumar A., Nigam A., Girdhar B. K. 2006b; Detection of antibodies against Mycobacterium leprae culture filtrate protein-10 in leprosy patients. J Med Microbiol 55:1337–1341 [CrossRef]
   [Google Scholar]
8. Parkash O., Pandey R., Kumar A., Kumar A. 2007; Performance of recombinant ESAT-6 antigen (ML0049) for detection of leprosy patients. Lett Appl Microbiol 44:524–530 [CrossRef]
   [Google Scholar]
9. Reece S. T., Ireton G., Mohamath R., Guderian J., Goto W., Gelber R., Groathouse N., Spencer J., Brennan P., Reed S. G. 2006; ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy. Clin Vaccine Immunol 13:333–340 [CrossRef]
   [Google Scholar]
10. Spencer J. S., Dockrell H. M., Kim H. J., Marques M. A., Williams D. L., Martins M. V., Martins M. L., Lima M. C., Sarno E. N. other authors 2005; Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J Immunol 175:7930–7938 [CrossRef]
    [Google Scholar]
11. World Health Organization 1988; WHO Expert Committee on Leprosy, Geneva. World Health Organ Tech Rep Ser 768:1–51
    [Google Scholar]
12. World Health Organization 1998; WHO Expert Committee on Leprosy, Geneva. World Health Organ Tech Rep Ser 874:1–43
    [Google Scholar]
13. World Health Organization 2005; Global strategy for further reducing the leprosy burden and sustaining leprosy control activities. Lepr Rev 76:265–287
    [Google Scholar]